Exom Group (now Kapadi)

We are excited to announce that Exom Group has merged with OncoBay Clinical and Clinscience, and is now operating under a new unified brand: Kapadi. Therefore, the LinkedIn Profiles were merged as well: https://www.linkedin.com/company/kapadi/ This transformative merger brings together three companies' extensive expertise and resources, creating a premier provider of global technology- and data-driven oncology clinical trial services. By leveraging our combined strengths, Kapadi is uniquely positioned to support your future trials with unparalleled efficiency, innovation, and scientific excellence. We look forward to partnering with you to advance the development of novel cancer therapies and improve patient outcomes worldwide. ----- Exom Group is “The Human Digital CRO”, that provides value-added services through digital applications for clinical development of drugs & medical devices. Exom combines the strong medical, regulatory and operational expertise of his staff, with the most disruptive digital cloud and mobile solutions to reduce costs and increase quality and performance of clinical trials. Exom will be the Preferred Partner for those life science companies who recognize that implementing digital solutions is not as simple as installing innovative technologies but really a fundamental change in the way they do clinical trials with a higher attention to both investigators and patient’s needs. Exom helps in containing the costs, reducing the time to market, facing the regulatory pressures and managing the complexity and the level of the burden in clinical operations. Exom Alliance, a network of validated partners, provides a qualified, flexible and established organization of experienced clinical research professionals active across the whole of Europe and USA, all trained and familiar with Exom’s technologies and processes.